Daptomycin

NDC 60505-6229 · APOTEX CORP.

Generic nameDaptomycin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DAPTOMYCIN

Strength500 mg/10mL

Pharmacologic classLipopeptide Antibacterial [EPC], Lipopeptides [CS]

Marketing categoryANDA

Packages

60505-6229-4 — 1 VIAL, SINGLE-USE in 1 CARTON (60505-6229-4) / 10 mL in 1 VIAL, SINGLE-USE

J0878 — Injection, daptomycin, 1 mg Medicare Part B payment limit (ASP + 6%): $0.03

FDA lists these products with the same active ingredient.

16729-434 — Daptomycin, 16729-435 — Daptomycin, 25021-174 — daptomycin, 25021-179 — Daptomycin, 31722-215 — Daptomycin, 31722-216 — Daptomycin, 42023-295 — Daptomycin, 43598-413 — Daptomycin, 43598-476 — Daptomycin, 55150-344 — DAPTOMYCIN, 60977-145 — daptomycin, 63323-371 — Daptomycin, 67184-0549 — Daptomycin, 67457-813 — daptomycin, 67457-941 — daptomycin, 68001-376 — Daptomycin, 70377-093 — Daptomycin, 70436-033 — daptomycin, 70511-182 — Daptomycin, 70594-034 — Daptomycin, +25 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.